Health Catalyst (HCAT) Operating Leases (2018 - 2026)

Health Catalyst's Operating Leases history runs 9 years deep, the most recent figure standing at $13.5 million for Q1 2026.

• Quarterly Operating Leases fell 14.41% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (down 14.41% YoY) and the FY2025 annual result came in at $14.2 million, down 28.62% from the prior year.
• Operating Leases was $13.5 million for Q1 2026 at Health Catalyst, down from $14.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $21.5 million in Q4 2022 and bottomed at $13.5 million in Q1 2026.
• A 5-year average of $17.4 million and a median of $17.4 million in 2023 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2024 — Operating Leases gained 12.61% — and 2025, when it fell 28.62%.
• Health Catalyst's Operating Leases stood at $21.5 million in 2022, then retreated by 17.6% to $17.7 million in 2023, then rose by 12.61% to $19.9 million in 2024, then decreased by 28.62% to $14.2 million in 2025, then fell by 5.11% to $13.5 million in 2026.
• Business Quant data shows HCAT's Operating Leases at $13.5 million in Q1 2026, $14.2 million in Q4 2025, and $15.1 million in Q3 2025.